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Abstract 
Present study was designed to evaluate in effect of Hesperidine on renal complication 
in Ischemia/reperfusion (I/R) induced renal damage in Sprague dawley diabetic rats. 
Hyperglycaemia is most probably a contributing factor in the development of 
ischaemic acute renal failure (ARF) in many patients. Both clinical and experimental 
data suggest that hyperglycaemia increases the risk of ARF. Type 2 Diabetes was 
induced in rats by a single intraperitoneal (i.p) injection of Streptozotocin (65 mg/kg, 
STZ) in overnight fasting rats followed by the i.p administration of Nicotinamide (110 
mg/kg, NIC) after 15 minutes. After right nephrectomy, Hesperidine (100 mg/kg/day, 
p.o) was administered for 15 days. On the 16th day, ischemia was induced in contra 
lateral kidney for 45 min, followed by reperfusion for 24 hr. Renal function marker and 
oxidative parameter were estimated at the end of 24 hr reperfusion. At the end of 
experimental period the level of malondialdehyde formation/ lipid peroxidation (LPO) 
in kidney tissue and serum marker Creatinine, Urea and Uric acids were significantly 
increased. Whereas, the activity of biomarkers of oxidative stress such as reduced 
glutathione (GSH), catalase (CAT) and superoxide dismutase (SOD) were found to be 
decreased significantly compared to control rats. Hesperidine improved the renal 
dysfunction and oxidative stress after renal ischemia/reperfusion injury in diabetic rats. 
In conclusion, Hesperidine shows potent may improve renal complication in I/R 
induced renal damage in type 2 diabetic rats. 
 
1. Introduction 
Hyperglycaemia is most probably a 
contributing factor in the development of 
ischaemic acute renal failure (ARF) in many 
patients. Both clinical and experimental data 
suggest that hyperglycaemia increases the risk of 
ARF (1-3). Hyperglycaemia also worsens the 
outcome in renal transplantation (4). Conversely, 
ischemia/reperfusion (I/R) combined with 
hyperglycaemia could also be important in the 
development of diabetic nephropathy.  
Organ injury as a consequence of ischemia 
followed by reperfusion is a major clinical problem. 
Renal ischemia/reperfusion (I/R) injury is the most 
common cause of acute renal failure as seen after 
renal transplantation, major abdominal and vascular 
surgery, coronary bypass surgery, and in trauma and 
sepsis (5). 
In the setting of loss of renal blood flow 
autoregulation that characterizes the post-ischemic 
kidney (6), Renal I/R injury is a major cause of 
acute renal failure (7), which is faced in many 
clinical situations such as kidney transplantation, 
partial nephrectomy, renal artery, angioplasty, aortic 
aneurysm surgery, and elective urological 
operations. In these conditions, I/R injury initiates 
a complex and interrelated sequence of events, 
resulting in injury to and the eventual death of renal 
cells (5, 8). Several factors have been implicated in 
the pathophysiological changes occurring while 
renal I/R injury including vascular or microvascular 
injury, endothelial dysfunction, accelerated cell 
necrosis, granulocyte activation, and modulation of 
nitric oxide/angiotensin II axis (9, 10).  
The rennin-angiotensin system plays a pivotal 
role in regulation of blood pressure. Renin acts on 
angiotensinogen to form angiotensin I, which is 
converted to angiotensin II with the help of 
angiotensin-converting enzyme (ACE) (11). 
Angiotensin II is an important mediator in kidney 
injury. Accumulating evidence suggests that 
angiotensin II stimulates intracellular formation of 
reactive oxygen species (ROS) such as the 
superoxide anion and hydrogen peroxide that leads 
to kidney damage (12). 
Hesperidin (HES) is an abundant and 
inexpensive byproduct of Citrus cultivation and 
isolated from the ordinary orange Citrus aurantium 
and other species of the genus Citrus (family: 
Rutaceae). It is reported to have anti-allergic, radio 
protective, immunomodulator, anti-hypertensive 
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and anti-oxidant properties. When Hesperidin is 
administered orally, it is hydrolyzed by intestinal 
micro flora to yield a major active metabolite 
Hesperidin. 
The present study, we investigated the 
protective effect of Hesperidine on renal marker 
and oxidative stress of kidney in diabetic rats and 
other word effect of Hesperidine on reduced on 
experimentally induced ischemia/reperfusion 
induced renal damage in diabetic rats. 
2. Materials and Methods 
Drugs and Chemicals 
Hesperidin was obtained from ACROS Lab, 
US. STZ and NIC were obtained from SIGMA, St. 
Louis, MO, USA. All other chemicals and reagents 
used in the study were of analytical grade. 
Experimental Animals 
All experiments and protocols described in 
present study were approved by the Institutional 
Animal Ethics Committee (IAEC) of Dharmaj 
Degree Pharmacy College, Anand. Sprague Dawley 
rats (210 ± 15 g) were housed in-group of 3 
animals per cage and maintained under 
standardized laboratory conditions (12- h 
light/dark cycle, 24°C) and provided free access to 
palleted CHAKKAN diet (Nav Maharashtra Oil 
Mills Pvt., Pune) and purified drinking water ad 
libitium. The animal experiment was approved by 
Animal Ethical Committee of the Institute 
(1163/a/08/CPCSEA). 
Experimental Induction of Type 2 
Diabetes in Rats  
Type 2 Diabetes was induced in rats by a 
single intraperitoneal (i.p) injection of 
Streptozotocin (65 mg/kg, STZ) in overnight 
fasting rats or mice followed by the i.p 
administration of Nicotinamide (110 mg/kg, NIC) 
after 15 minutes. STZ was dissolved in citrate 
buffer (pH 4.5) and NIC was dissolved in normal 
saline. After 7 days following STZ and NIC 
administration, blood was collected from retro-
orbital puncture and serum samples were analyzed 
for blood glucose (14).  Animals showing fasting 
blood glucose higher than 250 mg/dL were 
considered as diabetic and used for the further 
study.  
Experimental Protocol 
The rats were divided into three groups each 
consisting of six animals: 
Group 1:Animals served as sham-operated 
(underwent all surgical procedures without ischemia 
reperfusion).   
Group 2: After right nephrectomy on day 1, 
vehicle (100% sodium CMC) was administered for 
15 days; on day 16, ischemia was produced in the 
left kidney for 45 min, followed by reperfusion of 
24 hr (I/R control). 
Group 3: After right nephrectomy on day 1, 
Hesperidin (100 mg/kg/day, p.o.) was administered 
for 15 days; on day 16, ischemia was produced in 
the left kidney for 45 min, followed by reperfusion 
of 24 hr (I/R + HES). 
Surgical Procedure 
The progress of the experiment 
Day 1 Unilateral right nephrectomy 
Day 15 Treatment 
Day 16 45 minutes ischemia (left kidney) 
Day 17 24 hr reperfusion 
 
Right nephrectomy was performed through a 
right flank incision (2 cm) under general anesthesia, 
ketamine (100 mg/kg, i.p.). After right 
nephrectomy, several treatments were given as 
mentioned previously for 15 days. On day 16, 
ischemia was produced in the left kidney by 
performing a left flank incision and dissecting the 
left renal pedicle to expose the renal vessels. Non 
traumatic vascular clamps were used to stop blood 
flow (in artery and vein) for 45 min. Reperfusion 
was established by removing the clamp after 45 min 
ischemia. The abdominal wall (muscular layer and 
skin) was closed with 4.0 mononylon suture. At the 
end of reperfusion period (after 24 hr), blood 
samples were collected and used for the estimation 
of renal function (BUN and creatinine). The 
abdomen was opened, and the kidneys were 
harvested for the biomarkers of oxidative stress. 
Characterization of Type 2 Diabetes 
Model 
Type 2 diabetes was confirmed by measuring 
fasting serum glucose using standard diagnostic kit 
(SPAN diagnostics Pvt., India) and the degree of 
uncontrolled diabetic state was confirmed by 
measuring HbA1c  (Ion Exchange Resin method). 
After seven day, diabetes was confirmed by 
measuring glucose and HbA1c as mentioned above. 
Estimation of kidney function marker  
Blood was collected from the rats by retro-
orbital puncture at the time of sacrify and was 
allowed to clot for 10 minutes at room temperature. 
Clots were centrifuged at 2500 rpm for 10 minutes 
to separate the serum. Serum creatinine and urea 
levels were measured by assay kits (SPAN 
Diagnostics Pvt. India) and Serum Uric acid levels 
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were measured by assay kits (Crest Biosystems Ltd. 
India). 
Preparation of Tissue Homogenate 
After sacrificing the animals, their kidneys 
were quickly removed, perfused immediately with 
ice cold hypertonic saline solution, weighed and 
homogenized in chilled Tris buffer (10 mM, pH 7.4) 
at a concentration of 10% (w/v). The homogenates 
were centrifuged at 10,000×g at 0oC for 20 min 
using Remi C-24 high speed cooling centrifuge. The 
clear supernatant was used for the assay of 
following antioxidant parameters. The levels of 
Lipid peroxidation (LPO) formation and the 
activities of endogenous antioxidant enzymes such 
as catalase (CAT), reduced glutathione (GSH) and 
superoxide dismutase (SOD) were estimated by the 
method of Slater and Sawyer (15) Hugo Aebi as 
given by Hugo (16) Moron et al (17) and Mishra 
and Fridovich (18). 
Statistical Analysis 
All of the data are expressed as mean ± SEM. 
Statistical significance between more than two 
groups was tested using one-way ANOVA 
followed by the Bonferroni multiple comparisons 
test or unpaired two-tailed student’s t-test as 
appropriate using a computer-based fitting program 
(Prism, Graphpad 5). Differences were considered 
to be statistically significant when p < 0.05. 
 
Table 1. Effect of Streptozotocin (65mg/kg/day, p.o) and Nicotinamide (110 mg/kg/day, p.o) on serum glucose and HbA1c 
changes level in rats. 
 
Groups Glucose HbA1c 
CON 101.8 ± 6.799 5.455 ± 0.3729 
STZ + NIC 332.8 ± 9.167*** 9.900 ± 0.6323*** 
Values are expressed as mean ± SEM for six animals in the group. ***P<0.001 
considered statistically significant as compared to respective Control group. 
 
3. Results 
Characterization of Type 2 Diabetes 
Single intraperitoneal (i.p) injection of 
Streptozotocin (65mg/kg) followed by i.p 
administration of Nicotinamide (110 mg/kg) to rats 
produced severe hyperglycemia and increased 
HbA1c in 70 to 80 % the animals (Table 1). 
 
Figure 1. Effect of Hesperidine (100 mg/kg/day, p.o) on serum Creatinine (A), Urea (B), and Uric acid (C) in the diabetic rats 
exposed to renal ischemia/reperfusion (I/R) injury. 
                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are expressed as mean ± SEM for six animals in the group. ns = Non Significant, *P<0.05, **P<0.01, ***P<0.001 considered 
statistically significant as compared to respective Sham group.  
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Figure 2.Effect of Hesperidine (100 mg/kg/day, p.o) on Superoxide dismutase (A), Catalase(B), reduced glutathione (C) and lipid 
peroxidation (D) in the diabetic rats exposed to renal ischemia/reperfusion (I/R) injury. 
                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are expressed as mean ± SEM for six animals in the group. ns = Non Significant, *P<0.05, **P<0.01, ***P<0.001 considered 
statistically significant as compared to respective Sham group.  
 
Effect of HES on kidney function marker 
The six rats which underwent renal I/R 
exhibited a significant increase in the serum 
concentrations of creatinine (P < 0.001), urea (P < 
0.001), and uric acid (P < 0.001) compared with the 
sham control animals, suggesting a significant 
degree of glomerular dysfunction mediated by renal 
I/R. In I/R+HES treated diabetic rats, serum 
creatinine, urea and uric acid levels were 
significantly (p< 0.01, p< 0.01, p< 0.05, n = 6) 
higher as compared to I/R respectively Sham group 
alone (Fig.1). 
Effect of HES on antioxidant activity 
Renal I/R group of diabetic rats showed 
significantly decreased enzymatic activity of 
superoxide dismutage (P<0.001), catalase 
(P<0.001), and reduced glutathione (P<0.001) 
when compared with the sham control rats. These 
declining trends were significantly (P<0.05, Sham 
control Group) decreased in the group treated with 
HES compared with those in the I/R-only group 
(Fig. 2). Renal I/R produced a significant (P<0.001) 
increase in MDA levels in comparison with the 
sham operation in the rats. Treatment with PIO 
before renal I/R was associated with a significantly 
(P<0.05) lower MDA level than that in the rats that 
underwent only renal I/R (Fig. 2). 
 
4. Discussion 
The present study was under taken with the 
objective of exploring evaluate Hesperidine on 
renal marker in I/R induced renal damage in 
diabetic rats. The transient discontinuation of renal 
blood supply is encountered in many clinical 
situations such as kidney transplantation, partial 
nephrectomy, renal artery angioplasty, aortic 
aneurysm surgery, and elective urological 
operations (5, 8). This transient discontinuation 
causes renal I/R injury which results in decreased 
glomerular filtration and renal blood flow and 
increased urine output characterized by natriuresis 
and impaired concentrating ability. Much of this 
tubular and glomerular dysfunction has been 
postulated to occur during the reperfusion period 
following anoxia, and generation of ROS has been 
postulated as one of the major factors contributing 
to this reperfusion injury.   
Intracellular oxidative stress, due to an 
increased production of superoxide by the 
electrontransport chain in the mitochondria, has 
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been proposed as a unifying explanation for most 
metabolic alterations in diabetes (18). I/R are also a 
state where oxidative stress has been implied (19).  
Moreover, the levels of endogenous 
antioxidant (SOD, CAT and GSH) were reduced 
and lipid peroxidation increased in Sham group 
showing increased oxidative stress. In renal I/R 
injury, ROS are capable of reacting with lipids 
leading to lipid peroxidation of biological 
membranes, which in turn impacts enzymatic 
processes, such as ion pump activity, inhibiting 
transcription and repair of DNA. If lipid 
peroxidation remains unchecked, it will ultimately 
result in cell death (20). The finding that 
hyperglycaemia increases renal I/R injury may have 
implications for the understanding of diabetic 
nephropathy as well. Ischaemia has been suggested 
in the development of diabetic nephropathy (21). 
In our study, animals subjected to renal I/R 
demonstrated an increase in the renal MDA and at 
tenuated antioxidant enzymes pool. Lipid 
peroxidation and antioxidant enzymes are 
important indexes of oxidant injury (22). 
Demonstrations of lipid peroxidation as indexes for 
oxidative damage may help us better understand 
the effects of ROS on the cellular components 
(23).Renal I/R-induced oxidative stress was 
associated with impaired kidney function, leading to 
a marked increase in serum creatinine, urea, and 
uric acid levels. 
Pretreatment with Hesperidine prevented 
renal I/R-induced lipid peroxidation and protected 
the kidneys from severe attenuation of only one 
parameter antioxidant enzymes activity in rats 
exposed to the renal I/R. Furthermore, the low 
impaired kidney function was significantly 
improved by Hesperidine.  
The rennin-angiotensin system plays a pivotal 
role in regulation of blood pressure. Renin acts on 
angiotensinogen to form angiotensin-I, which is 
converted to angiotensin-II with the help of 
angiotensin-converting enzyme. Accumulating 
evidence suggests that angiotensin-II stimulates 
intracellular formation of ROS such as superoxide 
anion and hydrogen peroxide that leads to kidney 
damage (12). Generation of ROS has been 
postulated as one of the major factors contributing 
to this reperfusion injury. Oxidative stress can 
result from increased ROS production, and/or 
from decreased ROS scavenging capability. The 
ROS attach to the polyunsaturated fatty acids in the 
membrane lipids and result in peroxidation, which 
may lead to disorganization of cell structure and 
function. After reperfusion and reoxygenation, the 
imbalance between restoration of oxygen supply 
and mitochondrial respiratory function results in 
massive generation of superoxide anion in 
mitochondria (24). Under these conditions, the 
defensive system, which is known as antioxidant or 
antioxidant enzymes, cannot prevent the escape of 
ROS, especially in mitochondria, and their effects 
on other intracellular sites. This cascade of events is 
known as reperfusion injury (24).  
In this study, renal I/R increased oxidative 
stress products including tissue MDA and depleted 
the antioxidant enzymes pool, as is evident from 
the declined activity of superoxide dismutage, 
catalase, and reduced glutathione. It can be 
speculated that pretreatment with Hesperidine 
prevented renal I/R-induced lipid peroxidation and 
protected the kidneys from severe increasing of 
ROS products and depletion of superoxide 
dismutage and reduced glutathione in rats exposed 
to the renal I/R. 
 
Conclusions 
It is important to inhibit oxidative stress to 
prevent renal I/R injury in diabetic condition. Our 
data support a role for Hesperidine in attenuation 
of kidney damage after I/R injury of the kidneys in 
an animal model, in part at least by antioxidant or 
free radical scavanging activity. So, Hesperidine 
may reduce renal complication in experimentally 
induced renal damage in diabetic rats. 
 
Reference 
1. Wald H, Markowitz H, Zevin S, Popovtzer MM. 
Opposite effects of diabetes on nephrotoxic and 
ischemic acute tubular necrosis. Proc Soc Exp Biol 
Med 1990, 195: 51–56. 
2. Van den Berghe G, Wouters P, Weekers F et al. 
Intensive insulin therapy in the surgical intensive 
care unit. N Engl J Med 2001, 345: 1359–1367. 
3. Goor Y, Peer G, Iaina A et al. Nitric oxide in 
ischaemic acute renal failure of streptozotocin 
diabetic rats. Diabetologia 1996, 39: 1036–1040. 
4. Thomas MC, Mathew TH, Russ GR, Rao MM, 
Moran J. Early peri-operative glycaemic control and 
allograft rejection in patients with diabetes mellitus. 
a pilot study. Transplantation 2001, 72: 1321–1324 
5. Thadhani R, Pascual M, Bonventre JV. Acute 
renal failure. N Engl J Med., 1996 334:1448-60. 
6. Conger, J. Adv. Renal Replace. Ther. 4, Suppl. 
1997, 1: 25–37. 
7. Radhakrishnan J, Kiryluk K. Acute renal failure 
outcomes in children and adults. Kidney Int. 1997, 
69:17-9. 
8. Paller MS. Acute renal failure: controversies, 
clinical trials, and future directions. Semin Nephrol. 
1998, 18:482-9. 
9. Adam A, Raij L,. Nitric oxide--angiotensin II axis 
in renal and cardiovascular injury. J Nephrol. 2000, 
13:211-20. 
10. Maxwell SR, Lip GY. Reperfusion injury: a 
review of the pathophysiology, clinical 
49 
Journal of  Ecobiotechnology 2/2: 45-50, 2010 
manifestations and therapeutic options. Int J 
Cardiol. 1997, 58:95-117. 
11. Gavras HP, Salerno CM . The angiotensin 
II type 1 receptor blocker losartan in clinical 
practice: a review. Clin Ther. 1996, 18:1058-67. 
12. Sachse A, Wolf G. Angiotensin II-induced 
reactive oxygen species and the kidney. J Am Soc 
Nephrol. 2007, 18:2439-46. 
13. Masiello, P., Broca, C., Gross, R., Roye, M., 
Manteghetti, M., Hillaire -Buys, D., Novelli, M., 
Ribes, G.. Experimental NIDDM: development of 
a new model in adult rats administered 
Streptozotocin and Nicotinamide. Diabetes 1998, 47; 
224–229. 
14. Slater TF, Sawyer BC. The stimulatory 
effects of carbon tetrachloride and other halogeno 
alkanes or peroxidative reactions in rat liver 
fractions in vitro. Biochem J. 1971, 123:805– 14. 
15. Hugo EB. Oxidoreductases acting on groups 
other than CHOH: catalase. In:  Colowick SP, 
Kaplan NO, Packer L, editors. Methods in 
Enzymology, vol. 105. London 7 Academic Press 
1994, 121– 5. 
16. Moron MS, Depierre JW, Mannervik B. 
Levels of glutathione, glutathione reductase and 
glutathione S-transferase activities in rat lung and 
liver. Biochim Biophys Acta 1979, 582:67– 78. 
17. Mishra HP, Fridovich I. The role of 
superoxide anion in the autooxidation of 
epinephrine and a simple assay for superoxide 
dismutase. J Biochem 1992, 247:3170– 5. 
18. Brownlee M,. Biochemistry and molecular 
cell biology of diabetic complications. Nature 2001, 
414: 813–820.  
19. Chien CT, Lee PH, Chen CF, Ma MC, Lai 
MK, Hsu SM. De novo demonstration and co-
localization of free-radical production and 
apoptosis formation in rat kidney subjected to 
ischemiaureperfusion. J Am Soc Nephrol 2001, 2: 
973–982. 
20. Chatterjee PK, Cuzzocrea S, Brown PA, et 
al. Tempol, a membrane-permeable radical  
scavenger, reduces oxidant stress-mediated renal 
dysfunction and injury in the rat. Kidney Int. 2000, 
58:658-73. 
21. Ziyadeh FN. Significance of tubulointerstitial 
changes in diabetic renal disease. Kidney Int 1996, 
49: 10–13. 
22. Singh D, Chander V, Chopra K. The effect 
of quercetin, a bioflavonoid on 
ischemia/reperfusion induced renal injury in rats. 
Arch Med Res. 2004, 35:484-94. 
23. Muller DN, Dechend R, Mervaala EM, et al. 
NF-kappaB inhibition ameliorates angiotensin II-
induced inflammatory damage in rats. Hypertension 
2000, 35:193-201.  
24. Ozyurt H, Irmak MK, Akyol O, Sogut S. 
Caffeic acid phenethyl ester changes the indices of 
oxidative stress in serum of rats with renal 
ischaemia-reperfusion injury. Cell Biochem Funct. 
2001, 19:259-63. 
 
 
 
 
 
50 
